---
title: "Siga Tech | 8-K: FY2026 Q2 Revenue: USD 41 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295138302.md"
datetime: "2026-08-06T20:15:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295138302.md)
  - [en](https://longbridge.com/en/news/295138302.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295138302.md)
generator: "portal-rs"
---

# Siga Tech | 8-K: FY2026 Q2 Revenue: USD 41 M

Revenue: As of FY2026 Q2, the actual value is USD 41 M.

EPS: As of FY2026 Q2, the actual value is USD 0.17.

EBIT: As of FY2026 Q2, the actual value is USD 14.85 M.

#### Three Months Ended June 30, 2026 vs. 2025

-   **Product Sales and Supportive Services**
    -   SIGA Technologies, Inc. reported product sales and supportive services of $37,870,335 for the three months ended June 30, 2026, compared to $79,124,860 for the same period in 2025.
-   **Research and Development Revenue**
    -   Research and development revenue was $3,131,918 in 2026, up from $1,995,144 in 2025.
-   **Total Revenues**
    -   Total revenues for the three months ended June 30, 2026, were $41,002,253, a decrease from $81,120,004 in the prior year period.
-   **Cost of Sales and Supportive Services**
    -   Cost of sales and supportive services decreased to $17,561,185 in 2026 from $25,554,462 in 2025.
-   **Selling, General and Administrative Expenses**
    -   Selling, general and administrative expenses were $5,148,992 in 2026, down from $5,487,576 in 2025.
-   **Research and Development (Operating Expense)**
    -   Research and development operating expenses were $4,386,498 in 2026, a slight decrease from $4,398,097 in 2025.
-   **Total Operating Expenses**
    -   Total operating expenses decreased to $27,096,675 in 2026 from $35,440,135 in 2025.
-   **Operating Income**
    -   Operating income for SIGA Technologies, Inc. was $13,905,578 in 2026, significantly lower than $45,679,869 in 2025.
-   **Other Income, Net**
    -   Other income, net, was $946,898 in 2026, compared to $1,592,304 in 2025.
-   **Income Before Income Taxes**
    -   Income before income taxes was $14,852,476 in 2026, a reduction from $47,272,173 in 2025.
-   **Provision for Income Taxes**
    -   The provision for income taxes was -$2,389,042 in 2026, compared to -$11,789,070 in 2025.
-   **Net and Comprehensive Income**
    -   Net and comprehensive income for the quarter was $12,463,434 in 2026, down from $35,483,103 in 2025.

#### Six Months Ended June 30, 2026 vs. 2025

-   **Product Sales and Supportive Services**
    -   Product sales and supportive services were $41,408,212 for the six months ended June 30, 2026, a decrease from $84,946,107 in the prior year period.
-   **Research and Development Revenue**
    -   Research and development revenue increased to $5,836,622 in 2026 from $3,214,711 in 2025.
-   **Total Revenues**
    -   Total revenues for the six-month period were $47,244,834 in 2026, down from $88,160,818 in 2025.
-   **Cost of Sales and Supportive Services**
    -   Cost of sales and supportive services decreased to $20,502,069 in 2026 from $25,712,200 in 2025.
-   **Selling, General and Administrative Expenses**
    -   Selling, general and administrative expenses were $9,822,005 in 2026, compared to $11,163,238 in 2025.
-   **Research and Development (Operating Expense)**
    -   Research and development operating expenses increased to $8,336,344 in 2026 from $7,860,910 in 2025.
-   **Total Operating Expenses**
    -   Total operating expenses were $38,660,418 in 2026, a decrease from $44,736,348 in 2025.
-   **Operating Income**
    -   Operating income for SIGA Technologies, Inc. was $8,584,416 in 2026, significantly lower than $43,424,470 in 2025.
-   **Other Income, Net**
    -   Other income, net, was $2,224,378 in 2026, compared to $3,277,288 in 2025.
-   **Income Before Income Taxes**
    -   Income before income taxes was $10,808,794 in 2026, a decrease from $46,701,758 in 2025.
-   **Provision for Income Taxes**
    -   The provision for income taxes was -$1,799,610 in 2026, compared to -$11,626,878 in 2025.
-   **Net and Comprehensive Income**
    -   Net and comprehensive income for the six-month period was $9,009,184 in 2026, down from $35,074,880 in 2025.

#### Balance Sheet Highlights (as of June 30, 2026 vs. December 31, 2025)

-   **Cash and Cash Equivalents**
    -   Cash and cash equivalents decreased to $117,584,444 as of June 30, 2026, from $154,966,414 as of December 31, 2025.
-   **Total Current Assets**
    -   Total current assets were $170,377,782 as of June 30, 2026, compared to $212,856,864 as of December 31, 2025.
-   **Total Assets**
    -   Total assets decreased to $175,736,786 as of June 30, 2026, from $219,467,434 as of December 31, 2025.
-   **Total Current Liabilities**
    -   Total current liabilities decreased to $7,845,306 as of June 30, 2026, from $17,992,579 as of December 31, 2025.
-   **Total Liabilities**
    -   Total liabilities were $10,446,151 as of June 30, 2026, down from $20,645,862 as of December 31, 2025.
-   **Total Stockholders’ Equity**
    -   Total stockholders’ equity decreased to $165,290,635 as of June 30, 2026, from $198,821,572 as of December 31, 2025.

#### Operational Metrics and Capital Management

-   **Product Deliveries**
    -   In the second quarter of 2026, SIGA Technologies, Inc. delivered approximately $13 million of oral TPOXX to two international customers and approximately $24 million of IV TPOXX to the U.S. strategic national stockpile, completing the last procurement order under the 19C contract.
-   **Cash Flow**
    -   The provided report does not contain explicit details on operating cash flow or free cash flow.
-   **Capital Management**
    -   A special cash dividend of $0.60 per share was declared on March 26, 2026, and subsequently paid on April 23, 2026, to shareholders of record as of April 7, 2026.

#### Outlook / Guidance

-   The document does not contain specific forward-looking financial targets or guidance. Instead, it includes a disclaimer regarding various known and unknown risks and uncertainties that could cause actual results to differ materially from forward-looking statements. These risks encompass challenges in securing new U.S. Government contracts, completing the BARDA Contract, developing the international biodefense market, and obtaining regulatory approvals for products.

### Related Stocks

- [SIGA.US](https://longbridge.com/en/quote/SIGA.US.md)

## Related News & Research

- [Warren Buffett's Successor, Greg Abel, Has 82% of Berkshire's $360 Billion Portfolio Concentrated in 10 Superstar Stocks](https://longbridge.com/en/news/298708586.md)
- [REG - Central Asia Metals Barclays PLC - TR-1: Notification of major holdings](https://longbridge.com/en/news/298737485.md)
- [Twin Chokepoint Shock: Houthis Seize Mayyun Island In Bab el-Mandeb Strait As Hormuz Disruptions Persist](https://longbridge.com/en/news/298736530.md)
- [The Manufacturers Life Insurance Company Acquires 645,996 Shares of Liberty Media Corporation - Liberty Formula One Series C $FWONK](https://longbridge.com/en/news/298709002.md)
- ['It's a No-Brainer,' Says Top Investor About Alphabet](https://longbridge.com/en/news/298341611.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**